Foreign company group no longer interested in new standard for drug price determination.

The foreign drug company group has participated in the revising works for the price determination standard of new drugs but seems to withdraw its involvement probably on account of no chances for any desirable achievement.

The MOHW invited foreign representatives to the task force of revising the insurance drug price determination titled "The Price Determination Standard for Insurance New Dr...